fedra - risultati della ricerca

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

inrebic 100 mg capsule rigide

bristol-myers squibb sa - fedratinibum - capsule rigide - fedratinibum 100 mg ut fedratinibi dihydrochloridum monohydricum, cellulosum microcristallinum silicificatum, natrii stearylis fumaras corresp. natrium 0.18 mg, kapselhülle: gelatina, e 172 (rubrum), e 171, drucktinte: lacca, e 171, propylenglycolum, pro capsula. - primäre oder sekundäre myelofibrose - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

inrebic

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - agenti antineoplastici - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

fedra

bayer s.p.a. - gestodene ed estrogeno - gestodene ed estrogeno

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

fedra

medifarm s.r.l. - gestodene ed estrogeno - gestodene ed estrogeno

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)